Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Apr;47(4):350–352. doi: 10.1136/jcp.47.4.350

Non-transferrin bound iron and neutropenia after cytotoxic chemotherapy.

P Harrison 1, S S Marwah 1, R T Hughes 1, D Bareford 1
PMCID: PMC501940  PMID: 8027374

Abstract

AIMS--To investigate and characterise the appearance of non-transferrin bound iron (NTBI) in the serum of patients after cytotoxic chemotherapy and to compare this with the onset and duration of neutropenia. METHOD--Non-transferrin bound iron was measured by a bleomycin assay in patients undergoing intensive chemotherapy for treatment of acute leukaemia or lymphoma. RESULTS--NTBI was detected after 26 of 27 courses of chemotherapy and lasted for a mean of 14.5 days. The presence of NTBI correlated with the serum iron binding saturation, but not with serum ferritin. Neutropenia occurred after all courses of chemotherapy and lasted for a mean of 20.0 days. NTBI and neutropenia occurred concurrently after 23 courses of chemotherapy, and had a mean joint duration of 9.5 days. CONCLUSIONS--NTBI is consistently present in the serum of patients after cytotoxic chemotherapy, often at the same time as the patient is neutropenic. This may be an additional risk factor for the development of infective episodes after chemotherapy.

Full text

PDF
350

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Batey R. G., Lai Chung Fong P., Shamir S., Sherlock S. A non-transferrin-bound serum iron in idiopathic hemochromatosis. Dig Dis Sci. 1980 May;25(5):340–346. doi: 10.1007/BF01308057. [DOI] [PubMed] [Google Scholar]
  2. Brock J. H. Iron and infection. Haematologia (Budap) 1987;20(4):237–246. [PubMed] [Google Scholar]
  3. Brock J. H. The effect of iron and transferrin on the response of serum-free cultures of mouse lymphocytes to concanavalin A and lipopolysaccharide. Immunology. 1981 Jun;43(2):387–392. [PMC free article] [PubMed] [Google Scholar]
  4. Carbonetti N. H., Boonchai S., Parry S. H., Väisänen-Rhen V., Korhonen T. K., Williams P. H. Aerobactin-mediated iron uptake by Escherichia coli isolates from human extraintestinal infections. Infect Immun. 1986 Mar;51(3):966–968. doi: 10.1128/iai.51.3.966-968.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Caroline L., Rosner F., Kozinn P. J. Elevated serum iron, low unbound transferrin and candidiasis in acute leukemia. Blood. 1969 Oct;34(4):441–451. [PubMed] [Google Scholar]
  6. Fargion S., Cappellini M. D., Sampietro M., Fiorelli G. Non-specific iron in patients with beta-thalassaemia trait and chronic active hepatitis. Scand J Haematol. 1981 Feb;26(2):161–167. doi: 10.1111/j.1600-0609.1981.tb01641.x. [DOI] [PubMed] [Google Scholar]
  7. Gutteridge J. M., Hou Y. Y. Iron complexes and their reactivity in the bleomycin assay for radical-promoting loosely-bound iron. Free Radic Res Commun. 1986;2(3):143–151. doi: 10.3109/10715768609088066. [DOI] [PubMed] [Google Scholar]
  8. Gutteridge J. M., Rowley D. A., Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J. 1981 Oct 1;199(1):263–265. doi: 10.1042/bj1990263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Halliwell B., Aruoma O. I., Mufti G., Bomford A. Bleomycin-detectable iron in serum from leukaemic patients before and after chemotherapy. Therapeutic implications for treatment with oxidant-generating drugs. FEBS Lett. 1988 Dec 5;241(1-2):202–204. doi: 10.1016/0014-5793(88)81061-5. [DOI] [PubMed] [Google Scholar]
  10. Hunter R. L., Bennett B., Towns M., Vogler W. R. Transferrin in disease II: defects in the regulation of transferrin saturation with iron contribute to susceptibility to infection. Am J Clin Pathol. 1984 Jun;81(6):748–753. doi: 10.1093/ajcp/81.6.748. [DOI] [PubMed] [Google Scholar]
  11. Oppenheimer S. J. Iron and infection: the clinical evidence. Acta Paediatr Scand Suppl. 1989;361:53–62. doi: 10.1111/apa.1989.78.s361.53. [DOI] [PubMed] [Google Scholar]
  12. Potaznik D., Groshen S., Miller D., Bagin R., Bhalla R., Schwartz M., de Sousa M. Association of serum iron, serum transferrin saturation, and serum ferritin with survival in acute lymphocytic leukemia. Am J Pediatr Hematol Oncol. 1987 Winter;9(4):350–355. doi: 10.1097/00043426-198724000-00014. [DOI] [PubMed] [Google Scholar]
  13. Weinberg E. D. Iron withholding: a defense against infection and neoplasia. Physiol Rev. 1984 Jan;64(1):65–102. doi: 10.1152/physrev.1984.64.1.65. [DOI] [PubMed] [Google Scholar]
  14. van Asbeck B. S., Marx J. J., Struyvenberg A., van Kats J. H., Verhoef J. Effect of iron (III) in the presence of various ligands on the phagocytic and metabolic activity of human polymorphonuclear leukocytes. J Immunol. 1984 Feb;132(2):851–856. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES